胸膜炎治療の世界市場：2022年～2026年

世界の胸膜炎治療の市場規模は、2022年～2026年の間に2,461万米ドルの増加が見込まれ、予測期間中にCAGRで4.76％の成長が予測されています。

市場は、ウイルス感染症の新興国における調査、ヘルスケア分野向け研究開発の増加、医薬品の適正使用と流通のための取り組みによって牽引されています。

当レポートでは、世界の胸膜炎治療市場について調査分析し、市場規模・予測、動向、成長促進要因・課題、約25社のベンダーを網羅したベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年～2026年の予測

第4章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• サプライヤーの交渉力
• 新興企業の脅威
• 代替品の脅威
• 競合企業の脅威
• 市況

第5章 市場セグメンテーション：療法別

• 市場セグメント
• 比較：療法別
• 鎮痛剤 - 市場規模と予測：2021年～2026年
• 免疫グロブリン - 市場規模と予測：2021年～2026年
• 市場機会：療法別

第6章 顧客情勢

• 顧客情勢の概要

第7章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測：2021年～2026年
• 欧州 - 市場規模と予測：2021年～2026年
• アジア - 市場規模と予測：2021年～2026年
• その他の地域（ROW） - 市場規模と予測：2021年～2026年
• 米国 - 市場規模と予測：2021年～2026年
• カナダ - 市場規模と予測：2021年～2026年
• デンマーク - 市場規模と予測：2021年～2026年
• 中国 - 市場規模と予測：2021年～2026年
• ノルウェー - 市場規模と予測：2021年～2026年
• 市場機会：地域情勢別

第8章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第9章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• GlaxoSmithKline Plc
• Hudson Pharma
• Johnson and Johnson
• Merck and Co. Inc.
• Novartis AG
• Opsonin Pharma Ltd.
• Pfizer Inc.
• Reckitt Benckiser Group PLC
• Sanofi

第11章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
• Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Therapy
• Exhibits27: Data Table on Comparison by Therapy
• Exhibits28: Chart on Painkillers - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Painkillers - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Painkillers - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Painkillers - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• Exhibits36: Market opportunity by Therapy ($ million)
• Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits40: Chart on Geographic comparison
• Exhibits41: Data Table on Geographic comparison
• Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Norway - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on Norway - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on Norway - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Norway - Year-over-year growth 2021-2026 (%)
• Exhibits78: Market opportunity By Geographical Landscape ($ million)
• Exhibits79: Impact of drivers and challenges in 2021 and 2026
• Exhibits80: Overview on Criticality of inputs and Factors of differentiation
• Exhibits81: Overview on factors of disruption
• Exhibits82: Impact of key risks on business
• Exhibits83: Vendors covered
• Exhibits84: Matrix on vendor position and classification
• Exhibits85: Abbott Laboratories - Overview
• Exhibits86: Abbott Laboratories - Business segments
• Exhibits87: Abbott Laboratories - Key news
• Exhibits88: Abbott Laboratories - Key offerings
• Exhibits89: Abbott Laboratories - Segment focus
• Exhibits90: GlaxoSmithKline Plc - Overview
• Exhibits91: GlaxoSmithKline Plc - Business segments
• Exhibits92: GlaxoSmithKline Plc - Key news
• Exhibits93: GlaxoSmithKline Plc - Key offerings
• Exhibits94: GlaxoSmithKline Plc - Segment focus
• Exhibits95: Hudson Pharma - Overview
• Exhibits96: Hudson Pharma - Product / Service
• Exhibits97: Hudson Pharma - Key offerings
• Exhibits98: Johnson and Johnson - Overview
• Exhibits99: Johnson and Johnson - Business segments
• Exhibits100: Johnson and Johnson - Key news
• Exhibits101: Johnson and Johnson - Key offerings
• Exhibits102: Johnson and Johnson - Segment focus
• Exhibits103: Merck and Co. Inc. - Overview
• Exhibits104: Merck and Co. Inc. - Business segments
• Exhibits105: Merck and Co. Inc. - Key news
• Exhibits106: Merck and Co. Inc. - Key offerings
• Exhibits107: Merck and Co. Inc. - Segment focus
• Exhibits108: Novartis AG - Overview
• Exhibits109: Novartis AG - Business segments
• Exhibits110: Novartis AG - Key offerings
• Exhibits111: Novartis AG - Segment focus
• Exhibits112: Opsonin Pharma Ltd. - Overview
• Exhibits113: Opsonin Pharma Ltd. - Product / Service
• Exhibits114: Opsonin Pharma Ltd. - Key offerings
• Exhibits115: Pfizer Inc. - Overview
• Exhibits116: Pfizer Inc. - Product / Service
• Exhibits117: Pfizer Inc. - Key news
• Exhibits118: Pfizer Inc. - Key offerings
• Exhibits119: Reckitt Benckiser Group PLC - Overview
• Exhibits120: Reckitt Benckiser Group PLC - Business segments
• Exhibits121: Reckitt Benckiser Group PLC - Key offerings
• Exhibits122: Reckitt Benckiser Group PLC - Segment focus
• Exhibits123: Sanofi - Overview
• Exhibits124: Sanofi - Business segments
• Exhibits125: Sanofi - Key news
• Exhibits126: Sanofi - Key offerings
• Exhibits127: Sanofi - Segment focus
• Exhibits128: Inclusions checklist
• Exhibits129: Exclusions checklist
• Exhibits130: Currency conversion rates for US$
• Exhibits131: Research methodology
• Exhibits132: Validation techniques employed for market sizing
• Exhibits133: Information sources
• Exhibits134: List of abbreviations

Technavio has been monitoring the pleurodynia treatment market and it is poised to grow by $ 24.61 million during 2022-2026, accelerating at a CAGR of 4.76% during the forecast period. Our report on the pleurodynia treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of viral infections, increasing research and development in healthcare, and initiatives for the proper use and distribution of drugs.

The pleurodynia treatment market analysis includes the therapy segment and geographic landscape.

Technavio's pleurodynia treatment market is segmented as below:

By Therapy

• Painkillers
• Immunoglobulin

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing partnerships as one of the prime reasons driving the pleurodynia treatment market growth during the next few years. Also, the increasing number of mergers and acquisitions and technological advancements will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on pleurodynia treatment market covers the following areas:

• Pleurodynia treatment market sizing
• Pleurodynia treatment market forecast
• Pleurodynia treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pleurodynia treatment market vendors that include Abbott Laboratories, GlaxoSmithKline Plc, Hudson Pharma, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Opsonin Pharma Ltd., Pfizer Inc., Reckitt Benckiser Group PLC, and Sanofi. Also, the pleurodynia treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Therapy

• 5.1 Market segments
• Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
• 5.2 Comparison by Therapy
• Exhibit 26: Chart on Comparison by Therapy
• Exhibit 27: Data Table on Comparison by Therapy
• 5.3 Painkillers - Market size and forecast 2021-2026
• Exhibit 28: Chart on Painkillers - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Painkillers - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Painkillers - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Painkillers - Year-over-year growth 2021-2026 (%)
• 5.4 Immunoglobulin - Market size and forecast 2021-2026
• Exhibit 32: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
• 5.5 Market opportunity by Therapy
• Exhibit 36: Market opportunity by Therapy ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Canada - Market size and forecast 2021-2026
• Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.9 Denmark - Market size and forecast 2021-2026
• Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
• 7.10 China - Market size and forecast 2021-2026
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.11 Norway - Market size and forecast 2021-2026
• Exhibit 74: Chart on Norway - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Norway - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Norway - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Norway - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 81: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 83: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 84: Matrix on vendor position and classification
• 10.3 Abbott Laboratories
• Exhibit 85: Abbott Laboratories - Overview
• Exhibit 86: Abbott Laboratories - Business segments
• Exhibit 87: Abbott Laboratories - Key news
• Exhibit 88: Abbott Laboratories - Key offerings
• Exhibit 89: Abbott Laboratories - Segment focus
• 10.4 GlaxoSmithKline Plc
• Exhibit 90: GlaxoSmithKline Plc - Overview
• Exhibit 91: GlaxoSmithKline Plc - Business segments
• Exhibit 92: GlaxoSmithKline Plc - Key news
• Exhibit 93: GlaxoSmithKline Plc - Key offerings
• Exhibit 94: GlaxoSmithKline Plc - Segment focus
• 10.5 Hudson Pharma
• Exhibit 95: Hudson Pharma - Overview
• Exhibit 96: Hudson Pharma - Product / Service
• Exhibit 97: Hudson Pharma - Key offerings
• 10.6 Johnson and Johnson
• Exhibit 98: Johnson and Johnson - Overview
• Exhibit 99: Johnson and Johnson - Business segments
• Exhibit 100: Johnson and Johnson - Key news
• Exhibit 101: Johnson and Johnson - Key offerings
• Exhibit 102: Johnson and Johnson - Segment focus
• 10.7 Merck and Co. Inc.
• Exhibit 103: Merck and Co. Inc. - Overview
• Exhibit 104: Merck and Co. Inc. - Business segments
• Exhibit 105: Merck and Co. Inc. - Key news
• Exhibit 106: Merck and Co. Inc. - Key offerings
• Exhibit 107: Merck and Co. Inc. - Segment focus
• 10.8 Novartis AG
• Exhibit 108: Novartis AG - Overview
• Exhibit 109: Novartis AG - Business segments
• Exhibit 110: Novartis AG - Key offerings
• Exhibit 111: Novartis AG - Segment focus
• 10.9 Opsonin Pharma Ltd.
• Exhibit 112: Opsonin Pharma Ltd. - Overview
• Exhibit 113: Opsonin Pharma Ltd. - Product / Service
• Exhibit 114: Opsonin Pharma Ltd. - Key offerings
• 10.10 Pfizer Inc.
• Exhibit 115: Pfizer Inc. - Overview
• Exhibit 116: Pfizer Inc. - Product / Service
• Exhibit 117: Pfizer Inc. - Key news
• Exhibit 118: Pfizer Inc. - Key offerings
• 10.11 Reckitt Benckiser Group PLC
• Exhibit 119: Reckitt Benckiser Group PLC - Overview
• Exhibit 120: Reckitt Benckiser Group PLC - Business segments
• Exhibit 121: Reckitt Benckiser Group PLC - Key offerings
• Exhibit 122: Reckitt Benckiser Group PLC - Segment focus
• 10.12 Sanofi
• Exhibit 123: Sanofi - Overview
• Exhibit 124: Sanofi - Business segments
• Exhibit 125: Sanofi - Key news
• Exhibit 126: Sanofi - Key offerings
• Exhibit 127: Sanofi - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 128: Inclusions checklist
• Exhibit 129: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 130: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 131: Research methodology
• Exhibit 132: Validation techniques employed for market sizing
• Exhibit 133: Information sources
• 11.5 List of abbreviations
• Exhibit 134: List of abbreviations
  • health: Includes veterinary drugs (excluded from the scope of the report)